Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors

Not Applicable

Recruiting

Conditions: Prognostic Stage IB Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8

Interventions: Behavioral: Patient Navigation
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2023-01-06

Last Posted Date: 2024-03-20

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT05674578

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

Completed

Conditions: Breast Carcinoma

Interventions: Other: Interview

First Posted Date: 2022-10-18

Last Posted Date: 2023-03-02

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 31

Registration Number: NCT05583981

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases

Not Applicable

Recruiting

Conditions: Metastatic Malignant Solid Neoplasm
Metastatic Malignant Neoplasm in the Brain

Interventions: Behavioral: Neuropsychological Assessment
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2022-08-16

Last Posted Date: 2022-11-21

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 47

Registration Number: NCT05503251

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth

Not Applicable

Completed

Conditions: E-cigarette Use

Interventions: Other: ECIG lab session 1
Other: ECIG lab session 4
Other: ECIG lab session 2
Other: ECIG lab session 3
Other: ECIG lab session 5
Other: ECIG lab session 7
Other: ECIG lab session 8
Other: ECIG lab session 6

First Posted Date: 2022-07-14

Last Posted Date: 2024-11-22

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 88

Registration Number: NCT05458895

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study

Not Applicable

Completed

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Behavioral: Cigarette Smoking
Procedure: Computed Tomography
Procedure: Positron Emission Tomography
Other: Questionnaire Administration

First Posted Date: 2022-07-13

Last Posted Date: 2023-11-07

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT05455086

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hookah Additive Research to Inform Product Standards

Not Applicable

Completed

Conditions: Tobacco-Related Carcinoma

Interventions: Other: Questionnaire Administration
Behavioral: Tobacco Smoking

First Posted Date: 2022-07-12

Last Posted Date: 2023-11-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 54

Registration Number: NCT05453773

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases

Not Applicable

Recruiting

Conditions: Brain Metastases, Adult

Interventions: Other: Laboratory Biomarker Analysis
Other: Neurocognitive Assessment
Other: Questionnaire Administration
Device: Fitbit
Dietary Supplement: Dietary Intervention

First Posted Date: 2022-06-23

Last Posted Date: 2023-02-06

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 24

Registration Number: NCT05428852

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Early Phase 1

Recruiting

Conditions: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Endocrine Therapy-Induced Alopecia
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IA Breast Cancer AJCC v8

Interventions: Drug: Minoxidil
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2022-06-14

Last Posted Date: 2024-05-31

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 50

Registration Number: NCT05417308

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Early Phase 1

Recruiting

Conditions: Fallopian Tube Endometrioid Adenocarcinoma
Fallopian Tube Mucinous Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Ovarian Mucinous Adenocarcinoma
Ovarian Serous Adenocarcinoma
Primary Peritoneal Endometrioid Adenocarcinoma
Primary Peritoneal Serous Adenocarcinoma
Stage III Ovarian Cancer AJCC v8
Stage III Primary Peritoneal Cancer AJCC v8

Interventions: Drug: Carboplatin
Drug: Cisplatin
Procedure: Cytoreductive Surgery
Drug: Paclitaxel
Drug: Hyperthermic Intraperitoneal Chemotherapy
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2022-06-13

Last Posted Date: 2023-11-18

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 45

Registration Number: NCT05415709

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Not Applicable

Withdrawn

Conditions: Lung Non-Small Cell Carcinoma
Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Stage IA1 Lung Cancer AJCC v8
Head and Neck Squamous Cell Carcinoma
Stage IB Lung Cancer AJCC v8
Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Stage I Lung Cancer AJCC v8
Stage IA2 Lung Cancer AJCC v8

Interventions: Drug: Nicotine Replacement
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2022-06-09

Last Posted Date: 2024-04-12

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT05412875

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy